Johnson Matthey to Sell its Medical Device Components Business

UK’s Johnson Matthey (JM) has signed a definitive agreement to sell 100% of its Medical Device Components (MDC) business to Montagu Private Equity for $700 million (£550 million).

The MDC business, which produces components for medical devices with a focus on precious metal alloys and nitinol for global customers, operates manufacturing sites in San Diego, USA; Mexicali, Mexico; and Tullamarine, Australia.

With the sale of the MDC business and the already completed sale of its Battery Systems business, JM said that it has concluded the divestment program for its Value Businesses, originally announced in May 2022.

The transaction, which is subject to regulatory approval, is expected to be completed in the third quarter of 2024.

Liam Condon, CEO of Johnson Matthey, said: "Today’s announcement represents a significant milestone in our disposals program announced in May 2022. As a JM business, MDC has delivered technological differentiation and good growth to the critical health sector. We welcome Montagu’s plans to continue the investment and growth plans at MDC.”

"We are pleased that this concludes our Value Businesses disposal program which will deliver benefits to JM shareholders in terms of value realization, simplification and increased focus on our growth businesses, where JM has a proven ability to win," Condon added.

© Swapan - stock.adobe.com
© Swapan - stock.adobe.com

Company

Johnson Matthey

Orchard Road
SG8 5HE Royston, Herts
UK

Company contact







Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.